Evolving trade policy and the Trans-Pacific Partnership Agreement: Does it threaten Vietnam's access to medicine and its progress towards scaling up HIV prevention, treatment and care?

Global Public Health

Volumn 10, Issue , 2015, Pages S149-S160

  Linh, Nguyen Nhat ^a   Huong, Nguyen Thanh ^a   Thuy, Hua Thanh ^a  

^a HANOI UNIVERSITY OF PUBLIC HEALTH   (Viet Nam)

Author keywords

access to medicine; ARVs; intellectual properties; medicine price; Trans Pacific Partnership Agreement (TPP); Vietnam

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; ASIA; DRUG COST; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PACIFIC ISLANDS; PATENT; PATIENT CARE; PRIORITY JOURNAL; UNITED STATES; VIET NAM; COMMERCIAL PHENOMENA; ECONOMICS; HIV INFECTIONS; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; SUPPLY AND DISTRIBUTION;

ANTI-HIV AGENTS; COMMERCE; HEALTH POLICY; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; VIETNAM;

EID: 84921942547     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441692.2014.981829     Document Type: Article

References (20)

1. Drug Administration of Vietnam (DAV). (2012). Vietnam pharmaceutical general report. Unpublished report.
2. El Said, M., & Kapczynski, A. (2011). Access to medicines: The role of intellectual property law and policy. Working paper prepared for the Third Meeting of the Technical Advisory Group of the Global Commission on HIV and the Law, 7–9 July 2011. Retrieved from http://hivlawcommission.org/index.php/report-working-papers?task=document.viewdoc&id=86
3. Friel, S., Gleeson, D., Thow, A. M., Labonte, R., Stuckler, D., Kay, A., & Snowdon, W. (2013). A new generation of trade policy: Potential risks to diet risks to diet-related health from the Trans Pacific Partnership Agreement. Global Health, 9, 46. doi:10.1186/1744-8603-9-46
4. Foellmi, R., & Oechslin, M. (2010). Market imperfections, wealth inequality, and the distribution of trade gains. Journal of International Economics, 81(1), 15–25. doi:10.1016/j.jinteco.2010.03.001
5. Labonté, R., Blouin, C., & Forman, L. (2009). Trade and health. In A. Kay & O. D. Williams (Eds.), Global health governance: Crisis, institutions and political economy (pp. 182–197). Basingstoke: Palgrave Macmillan.
6. Ministry of Health. (2009). Circular No. 22/2009/TT-BYT. Retrieved from http://luatkhaiphong.com/Van-ban-Tieng-Anh/Circular-No.-22/2009/TT-BYT-dated-November-24-2009-4763.html
7. QSR International. (2006). NVivo qualitative data analysis software (version 7). Melbourne: QSR International.
8. Rohit, M. (2007). All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines. Oxfam Briefing Paper. Retrieved from http://www.oxfamamerica.org/files/Oxfam_US_Jordan_FTA_Briefing.pdf
9. Shaffer, E. R., & Brenner, J. E. (2009). A trade agreement's impact on access to generic drugs. Health Affairs, 28, w957–w968. doi:10.1377/hlthaff.28.5.w957
10. Socorro, E. (2013, June). The pharmaceutical law and national medicine policy: Assessment and recommendations. Paper presented at the National Medicine Policy Conference, Hanoi.
11. Trans-Pacific Partnership Negotiating Proposal. (2011a). Transparency chapter: Annex on transparency and procedural fairness for healthcare technologies (Leaked version). Retrieved from http://www.citizenstrade.org/ctc/wp-content/uploads/2011/10/TransPacificTransparency.pdf
12. Trans-Pacific Partnership Negotiating Proposal. (2011b). U.S. introduction to proposed TBT annexes on medical devices, pharmaceutical products and cosmetic products (Leaked version). Retrieved from http://www.citizenstrade.org/ctc/wp-content/uploads/2011/10/TransPacificTBTwMedicalAnnexes.pdf
13. Trans-Pacific Partnership Negotiating Proposal. (2013). Intellectual property rights chapter (Leaked version). Retrieved from https://wikileaks.org/tpp/
14. Tran, V. T., Hoang, T. P., Mathauer, I., & Nguyen, T. K. P. (2011). A health financing review of Vietnam with a focus on social health insurance: Bottlenecks in institutional design and organizational practice of health financing and options to accelerate progress towards universal coverage. Hanoi: Vietnam Medical Publishing House. Retrieved from http://www.who.int/health_financing/documents/oasis:f_11-vietnam.pdf
15. Tran, T. T. N., Tran, K. L., Bui, N. L., Theo, V., Ngo, D. A., & Nguyen, T. H. (2011). Viet Nam burden of disease and injury study 2008. Hanoi: Medical Publishing House. Retrieved from http://www.hsph.edu.vn/library/librarydoc/Ganh%20nang%20benh%20tat%20va%20chan%20thuong%20o%20VN-Eng.pdf
16. Vietnam Agency for AIDS Control (VAAC). (2012). Viet Nam AIDS Response Progress Report 2012. Hanoi: National Committee for AIDS, Drug and Prostitution Prevention and Control. Retrieved from http://www.vaac.gov.vn/Download.aspx/D0AF1DF472664BDDA427E8BC8442B34C/1/GARPR_Viet_Nam_2012_Eng.pdf
17. Vietnam Agency for AIDS Control (VAAC). (2013). Vietnam HIV/AIDS Response Progress Report 2013 and Plan for 2014. Retrieved from http://vaac.gov.vn/Desktop.aspx/Van-ban-phap-quy/Van-ban-phap-quy/557B9F557E0641949F5805C1F22F1EF4/
18. Vietnam Ministry of Health (MOH). (2011). Joint Annual Health Review 2011: Strengthening management capacity and reforming health financing to implement the five-year health sector plan 2011–2015. Hanoi: Author. Retrieved from http://jahr.org.vn/downloads/JAHR2011/JAHR2011_Fullversion_English.pdf
19. Vietnam Ministry of Health (MOH). (2013). Joint Annual Health Review 2013: Toward Universal Health Coverage. Hanoi: Author. Retrieved from http://jahr.org.vn/downloads/JAHR2013/JAHR2013_Final_EN.pdf
20. World Health Organization (WHO). (2006). Public health, innovation, and intellectual property rights: Report of the commission on intellectual property rights, innovation, and public health. Geneva: Author. Retrieved from http://www.who.int/intellectualproperty/report/en/